semaglutide tablets before and after Wegovy After: Real People, Real Results FDA-Approved Oral Semaglutide Pill |

As of mid-2025, retatrutide has not received marketing authorisation from the MHRA or EMA and is not available through the NHS or licensed private prescribers

doi: 10.1002/jcp.27603 140 ZhangS

Food and Drug Administration (FDA) in 2010 for type 2 diabetes

Prescribing GLP-1 agonists for AUD would constitute off-label use , which requires careful consideration of the evidence base, documented informed consent, clear rationale, appropriate monitoring, and adherence to local governance frameworks

In: ChemMedChem

Initial doses of 0.25 mg (7.5 units) increase by 0.25 mg weekly until reaching a therapeutic dose between 2.42.5 mg (7275 units) weekly, though individual protocols vary by provider and clinical context